Journal
MEDCHEMCOMM
Volume 2, Issue 4, Pages 270-273Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c0md00235f
Keywords
-
Funding
- BK-21
- MOEST of Korean government
Ask authors/readers for more resources
The per oral administration of compound 1, prepared by covalently attaching paclitaxel to a molecular carrier, shows good anti-tumor activity in the orthotopic mouse model of glioblastoma. The anti-tumor effects may be attributable to the cytotoxicity as well as the anti-angiogenic activity of the paclitaxel conjugate or paclitaxel itself in the brain parenchyma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available